Your browser doesn't support javascript.
loading
Lessons Learned from the COVID-19 Pandemic: Interpreting Vaccination Strategies in a Nationwide Demographic Study.
Kos, Igor Age; Hajar, Faissal Nemer; Sarot Pereira da Cunha, Gustavo; Corte, Claudia; Furlan, Luisa Augusto; Santa Maria, André; Valverde, Douglas; Emoingt Furtado, Bárbara; Morita Fernandes-Silva, Miguel; Feijó Azevedo, Valderilio.
Afiliação
  • Kos IA; Edumed Educação em Saúde, 2495 Bispo Dom José Street, Curitiba 80440-080, Brazil.
  • Hajar FN; Department of Internal Medicine I, Hematology, Oncology and Rheumatology, Saarland University Medical Center, Kirrbergstr. 100, 66424 Homburg, Germany.
  • Sarot Pereira da Cunha G; Edumed Educação em Saúde, 2495 Bispo Dom José Street, Curitiba 80440-080, Brazil.
  • Corte C; Edumed Educação em Saúde, 2495 Bispo Dom José Street, Curitiba 80440-080, Brazil.
  • Furlan LA; AstraZeneca Brazil, Raposo Tavares Road, KM 26.9, Cotia 06709-000, Brazil.
  • Santa Maria A; AstraZeneca Brazil, Raposo Tavares Road, KM 26.9, Cotia 06709-000, Brazil.
  • Valverde D; AstraZeneca Brazil, Raposo Tavares Road, KM 26.9, Cotia 06709-000, Brazil.
  • Emoingt Furtado B; Techtrials, Dr. Ovídio Pires de Campos Street, São Paulo 05403-010, Brazil.
  • Morita Fernandes-Silva M; AstraZeneca Brazil, Raposo Tavares Road, KM 26.9, Cotia 06709-000, Brazil.
  • Feijó Azevedo V; Edumed Educação em Saúde, 2495 Bispo Dom José Street, Curitiba 80440-080, Brazil.
Vaccines (Basel) ; 12(6)2024 May 26.
Article em En | MEDLINE | ID: mdl-38932310
ABSTRACT

OBJECTIVE:

Brazil was strongly affected by the COVID-19 pandemic. Its continental dimension and socio-demographic characteristics pose challenges to distribution and accessibility, making vaccination programs challenging. The objectives of the study were to describe the clinical and demographic characteristics of the general population vaccinated against COVID-19 by October 2021 and analyze the strategies implemented during the vaccination program. STUDY DESIGN AND

SETTING:

A retrospective nationwide study that analyzed data from the OpenDataSUS platform of the Informatics Department of the Brazilian Ministry of Health (DataSUS), which contains information from all individuals in Brazil who have received at least one dose of any vaccine against COVID-19 approved by the National Health Agency (ANVISA) from 17 January to 3 October 2021.

RESULTS:

Until 3 October, a total of 146,254,578 persons (68.6 per 100 inhabitants) received at least one dose of a vaccine in Brazil. The north and northeast regions had the lowest vaccination rates compared with the remaining regions (North 56.8, Northeast 62.0, South 74.4, and Southeast 73.2 per 100 inhabitants). Elderly individuals had the highest vaccination rates, particularly those above 70 years old. Heterologous dosing regimens were administered to 1,063,079 individuals (0.7% of those receiving the first dose).

CONCLUSIONS:

The COVID-19 vaccination program reached more than two-thirds of the population in Brazil by 9 months after its start, but the vaccination coverage was heterogeneous, reflecting the country's geographic and socio-demographic characteristics. Establishing priority groups for vaccination was a main characteristic of the vaccination strategy. In addition, technology transfer agreements have played an important role in increasing vaccine accessibility.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil